Outcomes in surgical stage I uterine papillary serous carcinoma
Authors:
- Laura J. HavrileskyLHLaura J. Havrilesky
- Angeles Alvarez SecordASAngeles Alvarez Secord
- Victoria Bae-JumpVBVictoria Bae-Jump
- Tina AyeniTATina Ayeni
- Brian CalingaertBCBrian Calingaert
- Daniel L. Clarke-PearsonDCDaniel L. Clarke-Pearson
- Andrew BerchuckABAndrew Berchuck
- Paola A. GehrigPGPaola A. Gehrig
- 1 June 2007
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 105 (3) , 677-682
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: A retrospective studyGynecologic Oncology, 2006
- HER-2 Is an Independent Prognostic Factor in Endometrial Cancer: Association With Outcome in a Large Cohort of Surgically Staged PatientsJournal of Clinical Oncology, 2006
- The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC)Gynecologic Oncology, 2005
- Uterine serous and grade 3 endometrioid carcinomasCancer, 2004
- Noninvasive papillary serous carcinoma of the endometriumObstetrics & Gynecology, 2001
- What Staging Surgery Should Be Performed on Patients with Uterine Papillary Serous Carcinoma?Gynecologic Oncology, 1999
- Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation (192Ir) and ChemotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Virulence of papillary endometrial carcinomaGynecologic Oncology, 1990
- Uterine papillary serous carcinomaAmerican Journal of Surgical Pathology, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958